Dr. Amisha Patel, MD

Dr. Patel practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Patel's NPI, 1649513656, was assigned on March 28, 2013. Dr. Patel graduated from UC Irvine School of Medicine in 2013. Dr. Patel holds California license 135035.

Dr. Patel's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Patel's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. Dr. Patel is also affiliated with Huntington Hospital. Dmand AI also links Dr. Patel to 1 more physician office and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Patel practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Patel's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Patel is board certified in internal medicine by the American Board of Internal Medicine. Dr. Patel is licensed in California.

Dmand AI lists cellulitis, chronic hypertension, circulatory problems in extremities, cirrhosis, congestive heart failure, coronary artery disease, electrolyte disorders and gastrointestinal bleeding among the conditions Dr. Patel treats.

CMS data shows 1,792 Medicare services from Dr. Patel across 6 procedure codes in 2024, for 381 Medicare patients. Medicare paid $200,688 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 381 Medicare patients who saw Dr. Patel in 2024. The largest group is 75 to 84, with 138 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 45% are also on Medicaid. Their average risk score is 3.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Patel's median patient age at 71, with 49% women.

In 2024, Dr. Patel wrote 309 Medicare Part D claims for 126 patients. 83% of them were for generic drugs. CMS names the drug for 33 of them, across 2 drugs with 11 or more claims each, at $75 in total drug cost. In 2022, CMS named 29 claims across 2 drugs.

Dr. Patel accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Patel, published from 2016 to 2018. The most frequent topics are Pacemaker, Artificial. Dr. Patel has published most often in Pacing Clin Electrophysiol. Dr. Patel's most frequent co-authors are Amisha Patel, MD, Imdad Ahmed, MD and Lynda E. Rosenfeld, MD.

CMS Open Payments shows 28 general payments to Dr. Patel from 14 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $718.

Dr. Patel graduated from UC Irvine School of Medicine in 2013.

Dr. Patel is in network with 5 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.